Charles River Laboratories: Digital Boost through Apollo Orchestrate and New Long-Term Goals
Reading Time: 3 minutes
The company aims for an annual organic revenue growth of 5 to 7% from 2027 to 2030, as well as an operating margin of around 24%. The new technology Apollo Orchestrate digitizes laboratory processes from sample submission to release and reduces administrative effort. Automation and paperless quality controls are intended to minimize audit risks and strengthen profitability as structural efficiency drivers. Foundation for Long-Term Growth Charles River Laboratories (CRL) focuses on providing essential services and products for the pharmaceutical...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
